12:00 AM
Oct 22, 2012
 |  BC Week In Review  |  Company News  |  Deals

Theravance, Merck deal

Theravance and Merck partnered to discover, develop and commercialize small molecules directed toward an undisclosed target for hypertension and heart failure. Theravance will be responsible for discovery,...

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >